Help Stop Cancer | digtriad.com | Triad, NC | Local and State News …
Tuesday, March 31, 2009
Find today's latest breaking Triad news headlines, updates, and coverage on North Carolina on digtriad.com.
![]() MSN Health & Fitness | Multiple CT Scans Raise Cancer Risk WebMD By Salynn Boyles March 31, 2009 -- As many as 7% of patients treated at a large US hospital received enough radiation exposure from repeated CT scans to increase their cancer risk, according to a new study. One in three patients included in the study ... As CT Radiation Accumulates, Cancer Risk May Rise U.S. News & World Report Repeat CT Scans May Boost Cancer Risk MedPage Today Multiple CT scans raise cancer risk Reuters UK WPBF - PR Web (press release) all 81 news articles |
![]() KCBS | US panel sees brain cancer benefit with Roche drug Reuters By Susan Heavey WASHINGTON (Reuters) - Early data for Roche Holding AG's drug Avastin shows enough promise in treating patients with a certain brain cancer to be considered for quick approval, a US advisory panel said on Tuesday. ... Roche’s Avastin Backed by US Panel for Brain Cancer Bloomberg BRIEF-US FDA panel backs data for Roche's Avastin brain cancer use Forbes FDA panel supports Avastin for brain cancer The Associated Press Wall Street Journal - Bizjournals.com all 165 news articles |
![]() CTV.ca | Attacking Liver Cancer With Highly Concentrated Chemo Dose RedOrbit, TX Researchers at the National Institutes for Health and other US hospitals are testing a super aggressive form of chemotherapy that targets cancer that has spread to the liver. In the new approach, known as percutaneous hepatic perfusion, or PHP, ... New liver cancer treatment shows promise abc7.com Super-chemo targets cancer spreading to the liver WOI Super-chemo targets cancer spreading to the liver The Associated Press all 292 news articles |
Intrinsic Bioprobes inks $1 million deal with National Cancer ... Bizjournals.com, NC Intrinsic Bioprobes Inc. secured a $1.13 million contract with the National Cancer Institute to develop technology to detect cancer-related proteins in the early stages of the disease. The Tempe biotech company kicked in another $146088 to help develop ... Intrinsic Bioprobes, Inc. Enters into a $1.27M Contract with the ... PR Newswire (press release) all 7 news articles |
Washington Times | US panel sees brain cancer benefit with Roche drug Reuters VX) drug Avastin shows enough promise in treating patients with a certain brain cancer to be considered for quick approval, a US advisory panel said on Tuesday. The drugmaker is seeking accelerated approval to market the drug for patients diagnosed ... BRIEF-US FDA panel backs data for Roche's Avastin brain cancer use Forbes FDA panel supports Avastin for brain cancer The Associated Press Genentech Is 'Confident' Avastin Meets FDA-Approval Standards Wall Street Journal FiercePharma - Reuters all 120 news articles |